Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT02801500
Other study ID # XJTU1AF-CRF-2015-001
Secondary ID
Status Recruiting
Phase N/A
First received May 29, 2016
Last updated September 19, 2017
Start date July 1, 2017
Est. completion date June 2019

Study information

Verified date September 2017
Source First Affiliated Hospital Xi'an Jiaotong University
Contact Yi Lv, MD,PHD
Phone 0086-13991200581
Email luyi169@126.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to determine whether the magnetic compressive anastomosis has a better outcomes than traditional manual anastomosis on superior bilioenteric anastomosis.


Description:

The superior bilioenteric anastomosis is one of the most common and difficult operations in Hepatobiliary Surgery. The traditional manual anastomosis has become one of the main prognosis factors because of the length of suture time, the difficulty of operation, the high incidence of anastomotic leakage and stricture. Magnetic compressive anastomosis can realize the fast anastomosis, reduce the difficulty, and reduce the incidence of anastomotic leakage and stricture. Currently, the majority of studies of magnetic compressive bilioenteric anastomosis are merely confined within clinical case report and single-center, small sample, retrospective study, thus they are lack of convictive evidence of evidence-based medicine for the security, reliability and convince.

This study is a multicenter, prospective, randomized controlled trial. To evaluate the security, reliability and convince of magnetic compressive superior bilioenteric anastomosis, this study compared the incidence of anastomotic leakage and stricture between magnetic compressive anastomosis and traditional manual anastomosis among patients who need superior bilioenteric anastomosis operation. The study design plan to enroll 70 patients and divide into Study Group (Group A: Magnetic compressive anastomosis) and Control Group (Group B: traditional manual anastomosis) as 1:1 ratio randomly by stratification factors. The incidence of anastomotic leakage and stricture, length of bilioenteric anastomosis time, value of serum bilirubin, length of discharge time of magnetic device and mean time of hospital stay will be evaluated. The patients will drop out of the study if adverse events happen, active request for dropping out, new-onset severe disease or death. The primary and secondary end point will be observed by regular follow-up.


Recruitment information / eligibility

Status Recruiting
Enrollment 70
Est. completion date June 2019
Est. primary completion date June 2018
Accepts healthy volunteers No
Gender All
Age group 18 Years to 75 Years
Eligibility Inclusion Criteria:

- Patients with age between 18 to 75

- Patients' gender was not limited

- Patients who were well-diagnosed and had the indication for superior bilioenteric anastomosis.

- Patients whose lifetimes will be longer than 12 months.

- Patients who are willing to join this clinical trial and informed consent form voluntarily.

Exclusion Criteria:

- Woman during pregnancy or lactation or anyone with mental disorder

- The wall of hepatic duct or jejunum was too thick so that the attractive force of magnetic device cannot meet the requirements of compression.

- Any anatomical variation in bile ducts system or the inner diameter is too small so that the magnetic device cannot place in.

- Any foreign body has been implanted in body, such as heart pacemaker.

- Surgical contraindication, including:

Child-Pugh C with hepatic encephalopathy Anyone with heart, lung, kidney dysfunction or other organ dysfunction, and cannot tolerate surgery.Hepatic ducts stone disease, who was diagnosed as Acute Cholangitis of Severe Type, especially complicated with bacteremia or septic shock. End stage disease, complicated with biliary cirrhosis or portal hypertension.Patients with long-term obstructive jaundice, dehydration, electrolyte disturbance or coagulation defects; Patients have the tendency or history of bleeding.

- Any other disease in perioperation periods which needs MRI examination in the next 8 weeks post operation.

Study Design


Intervention

Device:
Magnetic Compressive Anastomosis
The magnetic compressive anastomosis device will be used to complete the anastomosis during bilioenteric anastomosis.
Procedure:
Manual Anastomosis
A handsewn technique will be used to complete the anastomosis during bilioenteric anastomosis.

Locations

Country Name City State
China First Affiliated Hospital of Xian JiaotongUniversity Xi'an Shaanxi
China The First Affiliated Hospital of Xi'an Jiaotong University Xi'an Shaanxi

Sponsors (6)

Lead Sponsor Collaborator
First Affiliated Hospital Xi'an Jiaotong University First Affiliated Hospital of Xinjiang Medical University, First Affiliated Hospital, Sun Yat-Sen University, General Hospital of Ningxia Medical University, Shaanxi Provincial People's Hospital, Tang-Du Hospital

Country where clinical trial is conducted

China, 

References & Publications (8)

Avaliani M, Chigogidze N, Nechipai A, Dolgushin B. Magnetic compression biliary-enteric anastomosis for palliation of obstructive jaundice: initial clinical results. J Vasc Interv Radiol. 2009 May;20(5):614-23. doi: 10.1016/j.jvir.2009.01.019. — View Citation

Chopita N, Vaillaverde A, Cope C, Bernedo A, Martinez H, Landoni N, Jmelnitzky A, Burgos H. Endoscopic gastroenteric anastomosis using magnets. Endoscopy. 2005 Apr;37(4):313-7. — View Citation

Fan C, Ma J, Zhang HK, Gao R, Li JH, Yu L, Wu Z, Lv Y. Sutureless intestinal anastomosis with a novel device of magnetic compression anastomosis. Chin Med Sci J. 2011 Sep;26(3):182-9. — View Citation

Frattaroli FM, Reggio D, Guadalaxara A, Illomei G, Pappalardo G. Benign biliary strictures: a review of 21 years of experience. J Am Coll Surg. 1996 Nov;183(5):506-13. — View Citation

House MG, Cameron JL, Schulick RD, Campbell KA, Sauter PK, Coleman J, Lillemoe KD, Yeo CJ. Incidence and outcome of biliary strictures after pancreaticoduodenectomy. Ann Surg. 2006 May;243(5):571-6; discussion 576-8. — View Citation

Sicklick JK, Camp MS, Lillemoe KD, Melton GB, Yeo CJ, Campbell KA, Talamini MA, Pitt HA, Coleman J, Sauter PA, Cameron JL. Surgical management of bile duct injuries sustained during laparoscopic cholecystectomy: perioperative results in 200 patients. Ann — View Citation

Stepanov EA, Vasil'ev GS, Nikolaev VV. [The treatment of intestinal fistulae in children by applying a by-pass anastomosis using magnetic devices]. Khirurgiia (Mosk). 1992 Nov-Dec;(11-12):93-5. Russian. — View Citation

Yan JQ, Peng CH, Ding JZ, Yang WP, Zhou GW, Chen YJ, Tao ZY, Li HW. Surgical management in biliary restricture after Roux-en-Y hepaticojejunostomy for bile duct injury. World J Gastroenterol. 2007 Dec 28;13(48):6598-602. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Bilioenteric anastomotic leakage 1 month post operation
Secondary Length of bilioenteric anastomosis time during operation
Secondary Number of patients who have discharged the device on the date expected. 1 to 4 weeks postoperation
Secondary Number of patients who have been diagnosed as discharge disorder of magnetic device less than 1 week or more than 4 weeks
Secondary average length of postoperative hospital stay 3 months
Secondary Times of pathological examination of bile duct's remnant of Klatskin' tumor during operation
Secondary Bilioenteric anastomotic stricture Time Frame: 1,3,6,12-month post operation
See also
  Status Clinical Trial Phase
Recruiting NCT05678218 - Preoperative Evaluation of Lymph Nodes of Cholangiocarcinoma
Enrolling by invitation NCT01715402 - Optimization of Health Expenditure in Liver Surgery N/A
Completed NCT03320980 - RALPPS in Patients With Hilar and Intrahepatic Cholangiocarcinoma N/A
Completed NCT00721175 - Efficacy and Cost Analysis of Plastic Stent Compare to Metallic Stent in Hilar Cholangiocarcinoma Phase 4
Recruiting NCT05626127 - MRI-based Clinico-radiomics Predicting Lymph Node Metastasis Status of Hilar Cholangiocarcinoma
Terminated NCT02082522 - Efficacy and Safety Study of PDT Using Photofrin in Unresectable Advanced Perihilar Cholangiocarcinoma (OPUS) Phase 3
Active, not recruiting NCT05239169 - Immunotherapy With Durva and Treme With or Without Capecitabine in Adjuvant Treatment for Biliary Tract Cancer Phase 2
Recruiting NCT02178280 - Safety Study of Liver Transplantation for Hilar Cholangiocarcinoma Phase 1/Phase 2
Terminated NCT02955771 - Efficacy and Safety Study of PDT Using Deuteporfin for Unresectable Advanced Perihilar Cholangiocarcinoma Phase 2
Recruiting NCT03132649 - Impact of Three-dimensional Visualization on Operation Strategy and Complications for Hilar Cholangiocarcinoma
Recruiting NCT04561453 - Feasibility Study of Multi-Platform Profiling of Resected Biliary Tract Cancer
Recruiting NCT02108145 - Percutaneous Bilateral Versus Unilateral Metal Stent for Hilar Cholangiocarcinoma Phase 2/Phase 3
Enrolling by invitation NCT03739164 - Tampa Associating Microwave Liver Ablation With Portal Vein Ligation for Staged Hepatectomy (TAMLAPS)
Recruiting NCT01549795 - Liver Transplantation for Hilar Cholangiocarcinoma in Association With Neoadjuvant Radio- and Chemo-therapy N/A
Recruiting NCT06106750 - Endoscopic Scissors Cutting Nasobiliary Duct VS Bilateral Plastic Stent N/A
Active, not recruiting NCT02042443 - Trametinib or Combination Chemotherapy in Treating Patients With Refractory or Advanced Biliary or Gallbladder Cancer or That Cannot Be Removed by Surgery Phase 2
Recruiting NCT05551299 - Treatment of Non-resectable Bile Duct Cancer With Radiofrequency Ablation or Photodynamic Therapy Phase 4
Completed NCT01093222 - Sorafenib Tosylate and Erlotinib Hydrochloride in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gallbladder Cancer or Cholangiocarcinoma Phase 2
Enrolling by invitation NCT04779788 - I-125 Seeds Loaded Stent Insertion for Inoperable Hilar Cholangiocarcinoma N/A
Completed NCT04611100 - Efficacy of Intraductal Radiofrequency Ablation in Combination With Metallic Biliary Stenting in Advanced Hilar Cholangiocarcinoma N/A